| Literature DB >> 28484712 |
Rong Li1,2, Ai-Min Leng3, Ting Liu3, Yan-Wu Zhou4, Jun-Xian Zeng5, Xiao-Ming Liu1,2, Ting-Zi Hu1,2, Xiao-Xia Jiang1,2, Lin-Fang Zhang1,2, Can-Xia Xu1,2.
Abstract
Many factors have been reported to affect the long-term survival of gastric carcinoma patients after gastrectomy; the present study took the first attempt to find out the potential role of weekday carried out surgery in the postoperative prognosis of gastric cancer patients. 463 gastric cancer patients have been followed up successfully. Pearson χ2 test was used for univariate analyses. Survival curves were constructed by using Kaplan-Meier method and evaluated by using the log-rank test. The Cox proportional hazard regression model was used to find out the risk factors, and subgroup analysis was conducted to rule out confounding factors. We found that the patients who underwent gastrectomy on the later weekday (Wednesday-Friday) more easily suffered from a higher postoperative morbidity. Weekday of surgery was one of the independent indicators for the prognosis of patients after gastric cancer surgery. However, the role of weekday of surgery was significantly weakened in the complications group. In conclusion, surgery performed in the later weekday was more likely to lead to increased postoperative complications and an unfavorable role in prognosis of Chinese gastric cancer patients after curative gastrectomy.Entities:
Mesh:
Year: 2017 PMID: 28484712 PMCID: PMC5412209 DOI: 10.1155/2017/5090534
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
The clinicopathological characters of 463 patients subjected to curative gastrectomy.
| Characteristics |
| Monday-Tuesday | Wednesday–Friday |
|
|---|---|---|---|---|
| Gender | ||||
| Male | 224 | 102 | 122 | 0.26 |
| Female | 239 | 96 | 143 | |
| Age (year) | ||||
| ≤65 | 265 | 123 | 142 | 0.066 |
| >65 | 198 | 75 | 123 | |
| Smoking history | ||||
| No | 196 | 80 | 116 | 0.506 |
| Yes | 267 | 118 | 149 | |
| BMI | ||||
| Low BMI (<18 kg/m2) | 175 | 73 | 102 | 0.936 |
| Normal BMI (18–25 kg/m2) | 247 | 107 | 140 | |
| High BMI (>25 kg/m2) | 41 | 18 | 23 | |
| Comorbidities | ||||
| No | 340 | 139 | 191 | 0.670 |
| Yes | 123 | 49 | 74 | |
| ASA (0.000) | ||||
| I | 340 | 139 | 191 | 0.850 |
| II | 101 | 41 | 60 | |
| III | 22 | 8 | 14 | |
| Differentiation | ||||
| Undifferentiated | 23 | 10 | 13 | 0.611 |
| Differentiated | 440 | 188 | 252 | |
| Tumor size | ||||
| ≤5 cm | 322 | 136 | 186 | 0.76 |
| >5 cm | 141 | 62 | 79 | |
| Hypoproteinemia | ||||
| No | 250 | 115 | 135 | 0.133 |
| Yes | 213 | 83 | 130 | |
| Increased CEA | ||||
| No | 263 | 108 | 155 | 0.448 |
| Yes | 200 | 90 | 110 | |
| T classification | ||||
| T1 | 13 | 5 | 8 | 0.345 |
| T2 | 135 | 57 | 78 | |
| T3 | 276 | 114 | 162 | |
| T4 | 39 | 22 | 17 | |
| N classification | ||||
| N0 | 198 | 96 | 102 | 0.158 |
| N1 | 195 | 77 | 118 | |
| N2 | 53 | 18 | 35 | |
| N3 | 17 | 7 | 10 | |
| TNM stage | ||||
| I | 73 | 34 | 39 | 0.561 |
| II | 321 | 132 | 189 | |
| III | 69 | 32 | 37 | |
| Procedure (whether laparoscopic-assisted) | ||||
| No | 397 | 167 | 230 | 0.502 |
| Yes | 66 | 31 | 35 | |
| Medical team | ||||
| Group 1 | 167 | 69 | 98 | 0.757 |
| Group 2 | 155 | 70 | 85 | |
| Group 3 | 141 | 59 | 82 | |
| Chemotherapy | ||||
| No | 106 | 49 | 57 | 0.412 |
| Yes | 357 | 149 | 208 | |
| Operation time | ||||
| ≤240 min | 354 | 164 | 190 |
|
| >240 min | 109 | 34 | 75 | |
| Intraoperative blood loss | ||||
| ≤500 ml | 391 | 176 | 215 |
|
| >500 ml | 72 | 22 | 50 | |
| Postoperative complications | ||||
| Without | 362 | 164 | 198 |
|
| With | 101 | 34 | 67 | |
| Postoperative complications | ||||
| Grade 0 | 362 | 164 | 198 | 0.072 |
| Grade I | 45 | 19 | 26 | |
| Grade II | 28 | 9 | 19 | |
| Grade III | 17 | 5 | 12 | |
| Grade IV | 11 | 1 | 10 | |
| Postoperative CRP | ||||
| Normal CRP | 285 | 121 | 164 | 0.923 |
| Increased CRP | 178 | 77 | 101 |
Patients who took surgery on the later weekday were more inclined to get severe complications (Grade III + Grade IV).
| Grade 0 | Grade I | Grade II | Grade III | Grade IV | |
|---|---|---|---|---|---|
| Monday | 107 | 11 | 4 | 5 | 0 |
| Tuesday | 57 | 8 | 5 | 0 | 1 |
| Wednesday | 60 | 4 | 4 | 5 | 0 |
| Thursday | 60 | 7 | 5 | 3 | 6 |
| Friday | 78 | 15 | 10 | 4 | 4 |
Univariate cox analysis of overall and disease-free survival in 463 patients after gastrectomy.
| Characteristics | Overall survival | Disease-free survival | ||
|---|---|---|---|---|
| HR (95% CI) |
| HR (95% CI) |
| |
| Gender (female/male) | 1.190 (0.956–1.483) | 0.120 | 1.158 (0.939–1.428) | 0.171 |
| Age (year) (>65/≤65) | 1.126 (0.903–1.405) | 0.293 | 1.153 (0.933–1.424) | 0.187 |
| BMI (abnormal BMI/normal BMI) | 1.093 (0.878–1.361) | 0.426 | 1.079 (0.875–1.331) | 0.477 |
| Smoking history (yes/no) | 1.008 (0.808–1.258) | 0.945 | 1.015 (0.821–1.254) | 0.893 |
| Comorbidities (with/without) | 1.196 (0.936–1.527) | 0.152 | 1.282 (1.018–1.616) |
|
| ASA (III/I + II) | 1.277 (0.784–2.082) | 0.326 | 1.564 (0.996–2.457) | 0.052 |
| Tumor Size (≥5 cm/<5 cm) | 1.180 (0.932–1.494) | 0.169 | 1.320 (1.057–1.649) |
|
| Tumor differentiation (yes/no) | 0.818 (0.502–1.333) | 0.420 | 0.856 (0.526–1.394) | 0.533 |
| Increased serum CEA (yes/no) | 0.914 (0.732–1.140) | 0.425 | 0.960 (0.777–1.186) | 0.704 |
| Hypoalbuminemia (yes/no) | 1.032 (0.828–1.286) | 0.779 | 0.971 (0.787–1.198) | 0.783 |
| Laparoscopic-assisted (yes/no) | 0.883 (0.640–1.218) | 0.448 | 0.952 (0.705–1.284) | 0.745 |
| Operation time (≥240 min/<240 min) | 1.653 (1.295–2.112) |
| 1.495 (1.178–1.896) |
|
| Operative blood loss (≥500 ml/<500 ml) | 1.604 (1.212–2.125) |
| 1.509 (1.149–1.983) |
|
| T classification |
|
| ||
| (T2/T1) | 1.723 (0.697–4.260) | 0.239 | 1.239 (0.574–2.678) | 0.585 |
| (T3/T1) | 2.869 (1.181–6.967) |
| 2.042 (0.962–4.334) | 0.063 |
| (T4/T1) | 4.834 (1.889–12.366) |
| 3.105 (1.378–6.993) |
|
| N classification |
|
| ||
| (N1/N0) | 2.005 (1.571–2.558) |
| 2.280 (1.801–2.886) |
|
| (N2/N0) | 2.184 (1.521–3.136) |
| 2.805 (1.998–3.937) |
|
| (N3/N0) | 3.526 (1.984–6.268) |
| 3.900 (2.239–6.792) |
|
| TNM stage |
|
| ||
| (II/I) | 2.796 (1.877–4.167) |
| 2.929 (2.005–4.279) |
|
| (III/I) | 7.397 (4.679–11.692) |
| 7.874 (5.083–12.198) |
|
| Chemotherapy (no/yes) | 1.578 (1.231–2.023) |
| 1.771 (1.396–2.247) |
|
| Postoperative complications (yes/no) | 3.617 (2.825–4.631) |
| 3.395 (2.666–4.324) |
|
| Weekday (late/early) | 1.574 (1.255–1.974) |
| 1.488 (1.201–1.844) |
|
| Increased postoperative CRP (yes/no) | 1.857 (1.490–2.315) |
| 1.856 (1.503–2.293) |
|
Multivariate Cox regression analysis of overall and disease-free survival in 463 patients after gastrectomy.
| Characteristics | Overall survival | Disease-free survival | ||
|---|---|---|---|---|
| HR (95% CI) |
| HR (95% CI) |
| |
| Comorbidities (with/without) | — | — | 0.886 (0.636–1.233) | 0.472 |
| Tumor size (≥5 cm/<5 cm) | — | — | 1.055 (0.766–1.453) | 0.741 |
| Operation time (≥240 min/<240 min) | 0.869 (0.582–1.299) | 0.494 | 0.770 (0.520–1.139) | 0.191 |
| Operative blood loss (≥500 ml/<500 ml) | 1.023 (0.691–1.514) | 0.909 | 0.968 (0.662–1.417) | 0.869 |
| T classification |
|
| ||
| (T2/T1) | 2.315 (0.902–5.945) | 0.081 | 1.517 (0.670–3.433) | 0.318 |
| (T3/T1) | 3.691 (1.373–9.921) |
| 2.528 (1.062–6.020) |
|
| (T4/T1) | 4.001 (1.231–13.007) |
| 2.677 (0.920–7.789) | 0.071 |
| N classification |
|
| ||
| (N1/N0) | 1.790 (1.350–2.374) |
| 1.988 (1.515–2.608) |
|
| (N2/N0) | 1.953 (1.144–3.333) |
| 2.510 (1.515–4.157) |
|
| (N3/N0) | 2.838 (1.325–6.078) |
| 2.954 (1.422–6.138) |
|
| TNM stage |
|
| ||
| (II/I) | 1.182 (0.674–2.075) | 0.560 | 1.118 (0.654–1.912) | 0.684 |
| (III/I) | 2.520 (1.078–5.894) |
| 2.536 (1.114–5.773) |
|
| Postoperative complications (with/without) | 3.169 (2.388–4.204) |
| 2.826 (2.134–3.740) |
|
| Weekday (late/early) | 1.721 (1.343–2.205) |
| 1.693 (1.331–2.153) |
|
| Chemotherapy (no/yes) | 1.087 (0.830–1.423) | 0.546 | 1.204 (0.928–1.562) | 0.161 |
| Increased postoperative CRP (yes/no) | 1.399 (1.042–1.879) |
| 1.533 (1.150–2.045) |
|
Figure 1Weekday of surgery or postoperative complications influenced the overall survival time and disease-free survival time after gastrectomy. The 5-year overall survival rate and disease-free survival rate was much lower in the patients who underwent surgery on Wednesday to Friday than those on Monday to Tuesday (a, b). Similarly, the patients with postoperative complications shared a much shorter overall survival and disease-free survival time than those without complications (c, d).
The death and relapse rate after gastric cancer were increased from Monday to Friday through Wednesday.
| Weekday of surgery |
| HR (95% CI) |
| HR (95% CI) |
|---|---|---|---|---|
| Monday | 0.002 | 1 | 0.003 | 1 |
| Tuesday | 0.974 | 1.006 (0.695–1.457) | 0.823 | 0.961 (0.677–1.364) |
| Wednesday | 0.036 | 1.455 (1.025–2.065) | 0.121 | 1.302 (0.933–1.819) |
| Thursday | 0.001 | 1.724 (1.238–2.400) | 0.001 | 1.722 (1.259–2.355) |
| Friday | 0.005 | 1.559 (1.142–2.128) | 0.021 | 1.415 (1.054–1.901) |
Figure 2In the patients with postoperative complications, there was no significant difference between surgery on the earlier weekday and the later weekday in overall survival time and disease-free time (a, b). However, the weekday of surgery is still likely to influence the 5-year overall survival rate (c) in the patients without complications but not relapse rate (d).
Figure 3Regardless of weekday of surgery, the postoperative complications have a significant influence on the overall survival time and disease-free time after gastrectomy.